ArticleResearch square2026
Equine mesenchymal stromal cells dual-primed with TGF-β1 and IL-1β or TNF-α improve epithelial healing.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Background: Mesenchymal stromal cells (MSCs) secrete paracrine factors that contribute to their ability to promote tissue healing and regeneration. Priming equine MSCs with cytokines like TGF-β is known to enhance expression of growth factors and extracellular matrix molecules, which may increase their potential for treating certain injuries including epithelial wounds. We hypothesized that dual priming equine MSCs with TGF-β1 plus the inflammatory cytokines IL-1β or TNF-α would further increase expression of paracrine factors relevant to epithelial healing and their therapeutic potential. Results: Priming equine MSCs did not affect the morphology or viability of the cells. Equine MSCs dual-primed with TGF-β1 + IL-1β or TGF-β1 + TNF-α had increased expression of PGE2, AREG, and HBEGF. Conditioned media from both naïve and primed MSCs increased wound closure rates and dual-primed MSCs significantly increased the growth of colonoids in a co-culture model. Priming human induced MSCs did not stimulate the same changes in paracrine factor expression seen in equine MSCs. Conclusions: Priming equine MSCs with TGF-β1 + IL-1β or TGF-β1 + TNF-α is a promising strategy for generating cells or conditioned media with the necessary growth factors and cytokines for promoting epithelial healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.